Pay in 4 interest-free payments of $7.40 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Evolving procaspase-1-cleaving proteases with reduced off-target cleavage activity Although X(PC) demonstrated high selectivity for procaspase-1 over VAMP1, its transfection into mammalian cells lacking procaspase-1 (HEK293T cells) still resulted in reduced cell viability compared to a catalytically inactive X(PC) variant, consistent with residual off-target activity (Extended Data Fig
From the time it was introduced in 1955, acetaminophen has become one of the most successful OTC drugs, and has earned the primary manufacturer, Johnson & Johnson, an estimated US$1.3 billion every year
"Biochemical and phylogenetic characterization of a novel diaminopimelate biosynthesis pathway in prokaryotes identifies a diverged form of LL-diaminopimelate aminotransferase"
Providers can sign up for early access here: To view or add a comment, sign in More Relevant Posts PCAC Meeting Day 1 Results: BPC-157: YES KPV: YES TB-500: YES MOTS-c: YES Today the FDA's Pharmacy Compounding Advisory Committee voted to recommend all four peptides reviewed today for inclusion on the 503A Bulks List
US$ 20.80
US$ 29.88
US$ 28.53
US$ 25.11
US$ 28.37
US$ 25.14
US$ 22.00
:max_bytes(150000):strip_icc():format(webp)/benefits-of-glutathione-89457_final-01-502464fe91b2444285b0cccf8cb0a33c.png)
US$ 27.37
